Kewaunee Scientific (KEQU) Cash & Equivalents (2010 - 2026)

Kewaunee Scientific's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $1.7 million for Q2 2026.

• In Q2 2026, Cash & Equivalents fell 88.84% year-over-year to $1.7 million; the TTM figure through Apr 2026 stood at $1.7 million (down 88.84% YoY), while the FY2026 annual figure was $1.7 million, down 88.84% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $1.7 million, down from $2.2 million in the prior quarter.
• The five-year high for Cash & Equivalents was $26.0 million in Q4 2024, with the low at $952000.0 in Q3 2025.
• The 5-year median for Cash & Equivalents is $7.6 million (2022), against an average of $8.6 million.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents jumped 1052.88% in 2022, then sank 96.07% in 2025.
• Kewaunee Scientific's Cash & Equivalents stood at $9.4 million in 2022, then retreated by 15.18% to $8.0 million in 2023, then surged by 224.98% to $26.0 million in 2024, then sank by 51.49% to $12.6 million in 2025, then tumbled by 86.76% to $1.7 million in 2026.
• Business Quant data shows KEQU's Cash & Equivalents at $1.7 million in Q2 2026, $2.2 million in Q1 2026, and $12.6 million in Q4 2025.